U.S. Markets open in 7 hrs 14 mins

Adverum Biotechnologies, Inc. (ADVM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.3600-0.7000 (-22.88%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.22
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 319.2500
52 Week Low 32.2550
50-Day Moving Average 33.4512
200-Day Moving Average 37.9454

Share Statistics

Avg Vol (3 month) 33.41M
Avg Vol (10 day) 33.44M
Shares Outstanding 597.93M
Implied Shares Outstanding 6N/A
Float 61.95M
% Held by Insiders 10.81%
% Held by Institutions 198.50%
Shares Short (May 27, 2021) 49.57M
Short Ratio (May 27, 2021) 41.81
Short % of Float (May 27, 2021) 410.38%
Short % of Shares Outstanding (May 27, 2021) 49.77%
Shares Short (prior month Apr 29, 2021) 412.39M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-1,637.36%

Management Effectiveness

Return on Assets (ttm)-18.95%
Return on Equity (ttm)-34.24%

Income Statement

Revenue (ttm)7.5M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-73.31M
EBITDA -118.08M
Net Income Avi to Common (ttm)-123.04M
Diluted EPS (ttm)-1.3500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)404.02M
Total Cash Per Share (mrq)4.12
Total Debt (mrq)30.21M
Total Debt/Equity (mrq)7.28
Current Ratio (mrq)20.57
Book Value Per Share (mrq)4.24

Cash Flow Statement

Operating Cash Flow (ttm)-87.98M
Levered Free Cash Flow (ttm)-56.64M